Silver Book Fact

Survival rates of sSAS patients who do not undergo valve replacement

Patients with severe symptomatic aortic stenosis (sSAS) who do not undergo valve replacement have survival rates as low as 50% at two years and 20% at 5 years after the onset of symptoms.

Otto C. Timing of Aortic Valve Surgery. Heart. 2000; 84. http://heart.bmj.com/content/84/2/211

Reference

Title
Timing of Aortic Valve Surgery
Publication
Heart
Publication Date
2000
Authors
Otto C
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • Aortic valve disease costs
    Aortic valve disease (AVD) (symptomatic and asymptomatic) costs the U.S. $10.2 billion in direct costs each year.  
  • Lifespan of Medicare patients with sSAS who do not undergo treatment
    Medicare patients with severe symptomatic aortic stenosis (sSAS) who do not undergo treatment have an average lifespan of 1.8 years.  
  • Aortic stenosis impacts majority of heart valve disease patients
    Aortic stenosis (AS) is among the most common forms of heart valve disease (HVD), affecting 2% to 3% of the adult U.S. population.  
  • 2016 prevalence of aortic valve disease in America
    In 2016, as many as 5.8 million U.S. adults had aortic valve disease (AVD). Note: Alliance for Aging Research generated statistic, based on 2005 percentage prevalence estimates by Bach et al. 2007  
  • Survival rates for SAS patients without treatment